Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families.

International journal of urology : official journal of the Japanese Urological Association - 1 May 2007

Azzouzi Abdel-Rahene, Stoppa-Lyonnet Dominique, Roupret Morgan, Larre Stéphane, Mangin Philippe, Cussenot Oliver

Abstract excerpt

It is known that in some families an association exists between breast and prostate cancer. Several reports have suggested that BRCA2 mutations may be associated with an increased risk of these cancers. Herein, we report three cases of early onset of prostate cancer in families with female and ma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA2 Protein
Share to Breast Neoplasms
Share to BRCA2 gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Pedigree

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 17511731
DOI: 10.1111/j.1442-2042.2006.01712.x

Genes

BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17511731-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA2 mutation screening is clinically relevant in breast and early prostate cancer families.PMID 17511731Read ↗

The role of BRCA1 and BRCA2 in prostate cancer.Semantic proximity Read ↗

The role of the BRCA2 gene in susceptibility to prostate cancer revisited.Semantic proximity Read ↗

Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.Semantic proximity Read ↗

BRCA2 gene mutation and prostate cancer risk. Comprehensive review and update.Semantic proximity Read ↗

The relevance of BRCA genetics to prostate cancer pathogenesis and treatment.Semantic proximity Read ↗

Decreased prostate cancer-specific survival of men with BRCA2 mutations from multiple breast cancer families.Semantic proximity Read ↗

Prostate Cancer in a Patient with a Family History of BRCA Mutation: a Case Report and Literature Review.Semantic proximity Read ↗

Increased risk of male cancer and identification of a potential prostate cancer cluster region in BRCA2.Semantic proximity Read ↗

Prostate cancer in a man with a BRCA2 mutation and a personal history of bilateral breast cancer.Semantic proximity Read ↗

Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer.Semantic proximity Read ↗

BRCA2 mutation in a family with hereditary prostate cancer.Semantic proximity Read ↗

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.